MedPath

A Feasibility Study Of The Role Of Sentinel Lymph Node Detection In The Management Of Patients With Apparent Early Stage Endometrial Cancer

Not Applicable
Recruiting
Conditions
Endometrial Cancer
Cancer - Womb (Uterine or endometrial cancer)
Registration Number
ACTRN12612001279819
Lead Sponsor
Royal Women's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

Histologically confirmed endometrial cancer
Histologically confirmed complex atypical endometrial hyperplasia
Written informed consent

Exclusion Criteria

Suspected lymph node metastasis on preoperative MRI based on pre-set criteria
Any contra-indications to formal staging surgery e.g. co-morbidities
Inability to give informed consent
Poor understanding of English in absence of an interpreter
Inaccessible for follow up
Allergy to isotope or dye used
Previous cervical surgery like conisation
Age = 18 years
Evidence of metastatic disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the proportion of eligible patients in whom sentinel lymph nodes are identified successfully at the time of the surgery using the interventions outlined in the study.[At time of surgery]
Secondary Outcome Measures
NameTimeMethod
To identify the location of Sentinel Lymph Nodes in women with endometrial cancer and complex atypical hyperplasia using the interventions outlined in the study.[At time of surgery]
© Copyright 2025. All Rights Reserved by MedPath